125 related articles for article (PubMed ID: 36823769)
1. Clinical features of gestational choriocarcinoma: A retrospective bicentric study.
Yuksel D; Aytekın O; Oktar O; Ayhan S; Ozkaya Ucar Y; Cakır C; Boran N; Korkmaz V; Koc S; Türkmen O; Kimyon Cömert G; Moraloğlu Tekin O; Engin Ustün Y; Turan T
Asia Pac J Clin Oncol; 2024 Apr; 20(2):292-298. PubMed ID: 36823769
[TBL] [Abstract][Full Text] [Related]
2. Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study.
Braga A; Paiva G; Ghorani E; Freitas F; Velarde LGC; Kaur B; Unsworth N; Lozano-Kuehne J; Dos Santos Esteves APV; Rezende Filho J; Amim J; Aguiar X; Sarwar N; Elias KM; Horowitz NS; Berkowitz RS; Seckl MJ
Lancet Oncol; 2021 Aug; 22(8):1188-1198. PubMed ID: 34181884
[TBL] [Abstract][Full Text] [Related]
3. Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13.
Bolze PA; Riedl C; Massardier J; Lotz JP; You B; Schott AM; Hajri T; Golfier F
Am J Obstet Gynecol; 2016 Mar; 214(3):390.e1-8. PubMed ID: 26433171
[TBL] [Abstract][Full Text] [Related]
4. Is chemotherapy always necessary for patients with nonmetastatic gestational trophoblastic neoplasia with histopathological diagnosis of choriocarcinoma?
Braga A; Campos V; Filho JR; Lin LH; Sun SY; de Souza CB; da Silva RCAF; Leal EAS; Silveira E; Maestá I; Madi JM; Uberti EH; Viggiano M; Elias KM; Horowitz N; Berkowitz RS
Gynecol Oncol; 2018 Feb; 148(2):239-246. PubMed ID: 29248195
[TBL] [Abstract][Full Text] [Related]
5. [Preliminary study of PD-1 inhibitor in the treatment of drug-resistant recurrent gestational trophoblastic neoplasia].
Cheng HY; Yang JJ; Zhao J; Ren T; Feng FZ; Wan XR; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2020 Jun; 55(6):390-394. PubMed ID: 32842245
[No Abstract] [Full Text] [Related]
6. Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France.
Descargues P; Hajri T; Massardier J; Lotz JP; Devouassoux-Shisheboran M; Allias Montmayeur F; You B; Golfier F; Bolze PA
Am J Obstet Gynecol; 2021 Oct; 225(4):401.e1-401.e9. PubMed ID: 34019886
[TBL] [Abstract][Full Text] [Related]
7. Gestational trophoblastic neoplasia with brain metastasis at initial presentation: a retrospective study.
Gavanier D; Leport H; Massardier J; Abbas F; Schott AM; Hajri T; Golfier F; Bolze PA
Int J Clin Oncol; 2019 Feb; 24(2):153-160. PubMed ID: 30242539
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia.
Sato S; Yamamoto E; Niimi K; Ino K; Nishino K; Suzuki S; Kotani T; Kajiyama H; Kikkawa F
Int J Clin Oncol; 2020 Jan; 25(1):203-209. PubMed ID: 31520175
[TBL] [Abstract][Full Text] [Related]
9. Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial.
Cheng H; Zong L; Kong Y; Wang X; Gu Y; Cang W; Zhao J; Wan X; Yang J; Xiang Y
Lancet Oncol; 2021 Nov; 22(11):1609-1617. PubMed ID: 34624252
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
Song SQ; Zhang GN
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
[TBL] [Abstract][Full Text] [Related]
11. Treatment of extremely high risk and resistant gestational trophoblastic neoplasia patients in King Chulalongkorn Memorial Hospital.
Oranratanaphan S; Lertkhachonsuk R
Asian Pac J Cancer Prev; 2014; 15(2):925-8. PubMed ID: 24568520
[TBL] [Abstract][Full Text] [Related]
12. The effect of distance traveled on disease outcomes in gestational trophoblastic neoplasia.
Clark LH; Staley SA; Barber EL; Wysham WZ; Kim KH; Soper JT
Am J Obstet Gynecol; 2016 Aug; 215(2):217.e1-5. PubMed ID: 26875944
[TBL] [Abstract][Full Text] [Related]
13. EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.
Han SN; Amant F; Leunen K; Devi UK; Neven P; Vergote I
Int J Gynecol Cancer; 2012 Jun; 22(5):875-80. PubMed ID: 22635033
[TBL] [Abstract][Full Text] [Related]
14. [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia].
Shen T; Chen LL; Qin JL; Wang XY; Cheng XD; Xie X; Lyu WG
Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):371-376. PubMed ID: 29961278
[No Abstract] [Full Text] [Related]
15. Outcome of gestational trophoblastic neoplasia: experience from a tertiary cancer centre in India.
Gulia S; Bajpai J; Gupta S; Maheshwari A; Deodhar K; Kerkar RA; Seth V; Rekhi B; Menon S
Clin Oncol (R Coll Radiol); 2014 Jan; 26(1):39-44. PubMed ID: 24051171
[TBL] [Abstract][Full Text] [Related]
16. The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia.
Frijstein MM; Lok CAR; Short D; Singh K; Fisher RA; Hancock BW; Tidy JA; Sarwar N; Kanfer E; Winter MC; Savage PM; Seckl MJ
Eur J Cancer; 2019 Mar; 109():162-171. PubMed ID: 30731277
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy is not needed when complete evacuation of gestational choriocarcinoma leads to hCG normalization.
Bolze P; Schoenen S; Margaillan M; Braga A; Sauthier P; Elias K; Seckl M; Winter M; Coulter J; Lok C; Joneborg U; Undurraga Malinverno M; Hajri T; Massardier J; You B; Golfier F; Goffin F
Eur J Surg Oncol; 2024 Mar; 50(3):108012. PubMed ID: 38350264
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and prognosis of ultra high-risk gestational trophoblastic neoplasia patients: A retrospective cohort study.
Kong Y; Yang J; Jiang F; Zhao J; Ren T; Li J; Wang X; Feng F; Wan X; Xiang Y
Gynecol Oncol; 2017 Jul; 146(1):81-86. PubMed ID: 28461032
[TBL] [Abstract][Full Text] [Related]
19. Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.
Al-Husaini H; Soudy H; Darwish A; Ahmed M; Eltigani A; Edesa W; Elhassan T; Omar A; Elghamry W; Al-Hashem H; Al-Hayli S; Madkhali I; Ahmad S; Al-Badawi IA
Clin Transl Oncol; 2015 May; 17(5):409-15. PubMed ID: 25398721
[TBL] [Abstract][Full Text] [Related]
20. Postmolar choriocarcinoma: An independent risk factor for chemotherapy resistance in low-risk gestational trophoblastic neoplasia.
Strohl AE; Lurain JR
Gynecol Oncol; 2016 May; 141(2):276-280. PubMed ID: 26896825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
